mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
9e-06 |
mRNA |
AR-42 |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
9e-06 |
mRNA |
Compound 7d-cis |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
1e-05 |
mRNA |
pifithrin-mu |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
1e-05 |
mRNA |
FH535 |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
1e-05 |
mRNA |
BRD-K58730230 |
CTRPv2 |
pan-cancer |
AAC |
0.32 |
1e-05 |
mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
1e-05 |
mRNA |
BRD-K71935468 |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
2e-05 |
mRNA |
NSC95397 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
2e-05 |
mRNA |
Obatoclax Mesylate |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
3e-05 |